THEROUX
ACUTE CORONARY SYNDROMES
(HỘI CHỨNG MẠCH VÀNH CẤP)
PUBLISHER: ELSEVIER HEALTH SCIENCES (2011)
THÔNG TIN CHUNG:
Tiêu đề sách: Acute Coronary Syndromes (Hội chứng Mạch vành cấp)
Tác giả: Theroux
NXB: Elsevier Health Sciences (2011)
Số trang: 446
Cuốn sách được chia thành 35 chương cung cấp cho người đọc tất cả những hiểu biết, kiến thức về căn bệnh mạch vành cấp, một hội chứng tim mạch phổ biến trên thế giới; từ những thống kê, khảo sát cho tới những nghiên cứu phân tích chuyên sâu để đưa ra những dấu hiệu lâm sàng của bệnh, phương pháp điều trị, phòng ngừa bệnh mạch vành, là giáo trình cần thiết cho các sinh viên, giảng viên chuyên ngành y khoa tim mạch....
INTRODUCTION (GIỚI THIỆU):
At the beginning of the 20th century, coronary artery disease was considered to be a serious condition but the distinction between its two principal presentations, angina pectoris and acute myocardial infarction, was not clear. By the 1920s, the separate clinical and pathological manifestation of chronic angina pectoris and acute myocardial infarction had been established and their differences recognized. In the 1930s a condition characterized by prolonged chest pain that sometimes led to acute myocardial infarction was described, and by the 1940s a syndrome intermediate between angina pectoris and acute myocardial infarction, the so-called “intermediate syndrome“ was deemed to be quite common. In the early 1970s, the term unstable angina was coined and we now consider this designation to include patients with the new onset of severe angina, patients with accelerated angina, and those with angina at rest but without evidence of myocardial necrosis.
As unstable angina became more clearly defined, increasing attention was directed to the separation of patients with acute myocardial infarction into those who presented with and those without electrocardiographic ST segment elevation. It then became apparent that patients with unstable angina actually had or frequently developed the latter condition, that is, non−ST segment elevation myocardial infarction (NSTEMI).
By the 1990s, with the development of more sensitive biochemical markers of myocardial necrosis, the distinction between unstable angina and NSTEMI again became blurred.
Indeed, an increasing percentage of patients with the former condition were shown actually to have the latter. By the end of the 20th century, it became clear that from both pathophysiologic and clinical points of view that these two conditions should be considered together and they are now commonly referred to as non−ST segment elevation acute coronary syndromes (NSTE-ACS).
Research on acute coronary syndromes has exploded on many fronts and this impressive second edition of Acute Coronary Syndromes, edited by Pierre Théroux, masterfully captures the major developments. It carefully explores the many epidemiologic, clinical, pathophysiologic, and therapeutic advances in the field. The enormous frequency of this condition and its seriousness places it at ”the heart” of cardiology. Indeed, just about every adult cardiologist—whether an invasive or a non-invasive cardiologist, whether primarily office- or hospital-based, whether specializing in hypertension, heart failure, prevention, or rehabilitation—encounters patients with acute coronary syndromes and must be comfortable with their diagnosis and management.
Cardiologists dealing with these patients will be indebted to Dr. Théroux, an experienced clinician and investigator in this field, and his talented authors for providing this important new book. We are proud that it is a companion to Braunwald’s Heart Disease—A Textbook of Cardiovascular Medicine.
IMAGE PREVIEW (HÌNH ẢNH XEM TRƯỚC):
REFERENCES (TÀI LIỆU THAM KHẢO):
1. Heberden W: Some account of a disorder of the breast. Med Trans R Coll Physicians Lond 1772; 2: 59-67.
2. Osler W: The Lumleian lectures on angina pectoris. Lancet 1910; 1: 697-701.
3. Wood P: Therapeutic applications of anticoagulants. Trans Med Soc London 1948; 13: 80-85.
4. Braunwald E, Mark DB, Jones RH, et al: Unstable Angina: Diagnosis and Management. Clinical Practice Guideline, No. 10 (AHCPR Publ. No. 94-0602). Rockville, Md, U. S. Department of Health and Human Services, Agency for Health Care Policy and Research and the National Heart, Lung, and Blood Institute, U. S. Public Health Service, 1994.
5. Hamm CW, Ravkilde J, Gerhardt W, et al: The prognostic value of serum troponin T in unstable angina. N Engl J Med 1992; 327: 146-150.
6. Center for Outcomes Research, University of Massachusetts Medical School: Global Registry of Acute Coronary Events (GRACE) Registry, 2010. Available at http://outcomes-umassmed.org/grace.
7. Fox KAA, Steg PG, Eagle KA, et al: Decline in rates of death and heart failure in acute coronary syndromes, 1999-2006. JAMA 2007; 297: 1892-1900.
8. Halpern EJ. Triple-rule-out CT angiography for evaluation of acute chest pain and possible acute coronary syndrome. Radiology. 2009; 252: 332-345.
9. Reichlin T, Hochholzer W, Bassetti S, Steuer S, et al: Early diagnosis of myocardial infarction with sensitive cardiac troponin assays. N Engl J Med. 2009; 361: 858-867.
10. Heron M, Hoyert DL, Murphy SL, et al: Deaths: Final Data for 2006. National Vital Statistics Reports, U. S Department of Health and Human Services, Centers for Disease Control and Prevention, vol 57, no. 14. Available at http://cdc. gov/nchs/data/ nvsr/nvsr57/nvsr57_14. Pdf#28.
11. Bata IR, Gregor RD, Eastwood BJ, Wolf HK: Trends in the incidence of acute myocardial infarction between 1984 and 1993—the Halifax County MONICA Project. Can J Cardiol 2000; 16: 589-595.
12. Floyd KC, Yarzebski J, Spencer FA, et al: A 30-year perspective (1975-2005) Into the changing landscape of patients hospitalized with initial acute myocardial infarction. Worcester Heart Attack Study. Circulation 2009; 2: 88-95.
13. Furman MI, Dauerman HL, Goldberg RH, et al: Twenty-two-year (1975 to 1997) Trends in the incidence, in-hospital and long-term case-fatality rates from initial Q wave and non-Q wave myocardial infarction: A multi-hospital, community-wide perspective. J Am Coll Cardiol 2001; 37: 1571-1580.
14. Rogers WJ, Frederick PD, Stoehr E, et al: Trends in presenting characteristics and hospital mortality among patients with ST elevation and non-ST elevation myocardial infarction in the National Registry of Myocardial Infarction from 1990 to 2006. Am Heart J 2008; 156: 1026-1034.
15. Peterson ED, Roe MT, Mulgund J, et al: Association between between hospital process performance and outcomes among patients with acute coronary syndromes. JAMA 2006; 295: 1912-1920.
16. Montalescot G, Dallongeville J, Van Belle E, et al: STEMI and NSTEMI: Are they so different? 1 year outcomes in acute myocardial infarctionas defined by the ESC/ACC definition (the OPERA registry). Eur Heart J 2007; 28: 1409-1417.
17. James SK, Lindahl B, Siegbahn A, et al: N-terminal pro-brain natriuretic peptide and other risk markers for the separate prediction of mortality and subsequent myocardial infarction in patients with unstable coronary artery disease: A Global Utilization of Strategies To Open occluded arteries (GUSTO) -IV substudy. Circulation 2003; 108: 275-281.
18. Weber M, Bazzino O, Navarro Estrada JL, et al: N-terminal B-type natriuretic peptide assessment provides incremental prognostic information in patients with acute coronary syndromes and normal troponin T values upon admission. J Am Coll Cardiol 2008; 51: 1188-1195.
19. Ørn S, Manhenke C, Ueland T, et al: CƯreactive protein, infarct size, microvascular obstruction, and left-ventricular remodelling following acute myocardial infarction. European Heart J 2009; 30: 1180-1186
20. Biasucci LM, Liuzzo G, Grillo RL, et al: Elevated levels of CƯreactive protein at discharge in patients with unstable angina predict recurrent instability. Circulation 1999; 99: 855-860.
21. Heeschen C, Hamm CW, Bruemmer J, et al: Predictive value of CƯreactive protein and troponin T in patients with unstable angina: A comparative analysis. CAPTURE Investigators. Chimeric c7E3 AntiPlatelet Therapy in Unstable angina REfractory to standard treatment trial. J Am Coll Cardiol 2000; 35: 1535-1542.
22. Ridker PM, Cannon CP, Morrow D, et al: CƯreactive protein levels and outcomes after statin therapy. N Engl J Med. 2005; 352: 20-28.
23. Ridker PM, Danielson E, Fonseca FA, et al: Rosuvastatin to prevent vascular events in men and women with elevated CƯreactive protein. N Engl J Med. 2008; 359: 2195-2207.
24. Nikpoor B, Turecki G, Fournier C, et al: A functional myeloperoxidase polymorphic variant is associated with coronary artery disease in French-Canadians. Am Heart J 2001; 142: 336-339.
25. Zalewski A, Macphee C: Role of lipoprotein-associated phospholipase A2 in atherosclerosis: Biology, epidemiology, and possible therapeutic target. Arterioscler Thromb Vasc Biol 2005; 25: 923-931.
26. Kolodgie FD, Burke AP, Skorija KS, et al: Lipoprotein-associated phospholipase A2 protein expression in the natural progression of human coronary atherosclerosis. Arterioscler Thromb Vasc Biol 2006; 26: 25-23.
27. Garza CA, Montori VM, McConnell JP, et al: Association between lipoprotein-associated phospholipase A2 and cardiovascular disease: A systematic review. Mayo Clin Proc 2007; 82: 159-165.
28. Lp-PLA2 Studies Collaboration; Ballantyne C, Cushman M, Psaty B, et al: Collaborative meta-analysis of individual participant data from observational studies of Lp-PLA2 and cardiovascular diseases. Eur J Cardiovasc Prev Rehabil 2007; 14: 3-11.
29. O’Donoghue M, Morrow DA, Sabatine MS, et al: Lipoprotein-associated phospholipase A2 and its association with cardiovascular outcomes in patients with acute coronary syndromes in the PROVE ITƯTIMI 22 (PRavastatin Or atorVastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction) Trial. Circulation 2006; 113: 1745-1752.
30. Wilensky RL, Shi Y, Mohler ER 3rd, et al: Inhibition of lipoprotein-associated phospholipase A2 reduces complex coronary atherosclerotic plaque development. Nat Med 2008; 10: 1059-1066.
================================
Nhận xét
Đăng nhận xét